Enzo Life Sciences

What Enzo Life Sciences does

Enzo Life Sciences is a U.S.-headquartered (Farmingdale, NY) life-sciences tools company that operates as the reagents-focused commercial arm of Enzo Biochem Inc. (NYSE: ENZ). The company develops, manufactures, and distributes labeling and detection technologies — antibodies, ELISA kits, AMPIVIEW RNA probes for in situ hybridization/FISH, CELLESTIAL fluorescent-dye cell-based assays, and immunohistochemistry reagents — used across genomic, protein, cellular, tissue, and small-molecule chemistry workflows. Its portfolio is underpinned by 500+ issued patents and 175,000+ scientific citations, with manufacturing certified to ISO 9001 and ISO 13485 GMP standards. Strategic sub-brands include Enzo Therapeutics (immune regulation, gene technologies, cell-signaling modulation) and a Spatial Biology platform spanning genomics-to-tissue analysis.

The company monetizes through three primary streams: (1) one-time catalog sales of research reagents and kits via the enzo.com e-commerce storefront and global distributor network, (2) professional services revenue from GMP and contract manufacturing for biopharma and diagnostic customers, and (3) bulk-supply transactions for large-scale research and manufacturing operations. Pricing is quote-based rather than list-disclosed, with promotional discounts on select ELISAs and a "Worry-Free Guarantee" to reduce buyer friction. GTM is sales-led, combining direct enterprise engagement (including eProcurement integration) with distributor reach into academia, biotech/pharma, CROs, diagnostic manufacturers, and niche segments such as personal care and zoological research.

Historical growth has been substantially inorganic: Enzo Life Sciences was assembled through the acquisitions of Axxora (2007), BIOMOL International (2008, $18M), and Assay Designs (2009, $12.2M). Parent-company revenue has declined materially since 2021 (from ~$117.7M to ~$31.9M in 2024), reflecting corporate-level divestiture of the clinical-labs business and persistent operating losses at the public-company level. The remaining Life Sciences franchise is positioning for a turnaround through expanded biopharma services, spatial-biology offerings, and continued reagent-portfolio depth.

Name

Enzo Life Sciences

Legal name

Enzo Biochem Inc.

Website

https://enzolifesciences.com

Company type

Public

Founded year

1976

Operating status

Operating

Headcount range

101–250 employees

Short description

Enzo Life Sciences is a Farmingdale, NY-based life-sciences tools company developing labeling and detection reagents — antibodies, ELISA kits, AMPIVIEW RNA probes, and CELLESTIAL cellular assays — plus GMP manufacturing services for academic researchers, biotech/pharma firms, CROs, and diagnostic manufacturers, operating as a unit of Enzo Biochem Inc. (NYSE: ENZ).

Ownership category

akta.pro rank

Product category

Life Sciences Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

Keywords

• Life sciences reagents
• Research antibodies
• ELISA immunoassays
• Labeling detection technologies
• GMP contract manufacturing

Headquarters

HQ city

Farmingdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Product Sales (Research Reagents & Kits): Sale of life sciences research products including antibodies, ELISA kits, assay kits, and lab essentials through direct online ordering and distributor channels.
2. GMP & Contract Manufacturing Services: Custom manufacturing, packaging, and GMP services for biopharmaceutical and diagnostic manufacturers requiring quality-certified production capabilities.
3. Bulk Solutions: Bulk supply of reagents and products for large-scale research and manufacturing operations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Enzo Life Sciences manufactures and sells life sciences research reagents and diagnostic tools built around proprietary labeling and detection technologies covering genomic, protein, cellular, and tissue analysis. Core catalog items include AMPIVIEW RNA Probes, research antibodies, ELISA immunoassays, immunohistochemistry products, CELLESTIAL cell-based assays, and lab essentials, complemented by GMP-certified contract manufacturing, custom packaging, and bulk reagent services for biopharma and diagnostic manufacturers.

Product overview

Enzo Life Sciences operates as a life sciences reagents and diagnostics company offering a comprehensive portfolio across basic research and biopharma applications. The product ecosystem consists of technology platforms (genomic analysis, protein analysis, cellular analysis, tissue analysis, small molecule chemistry) and research fields (spatial biology, cancer, cardiovascular, immunology, metabolism, neuroscience). Core product sub-brands include AMPIVIEW® RNA Probes for in-situ hybridization, CELLESTIAL® Cellular Analysis for fluorescent dye-based assays, and ELISA Immunoassays for protein detection. Enzo Therapeutics provides therapeutic development capabilities in immune regulation, gene technologies, and cell signaling modulation. The company supplements its reagent portfolio with Life Sciences Contract Services including GMP Services, custom manufacturing, and bulk solutions for discovery through manufacturing workflows.

Differentiator

Problem solved

Functional benefit

Brands

• AMPIVIEW: RNA probes for in situ hybridization and FISH applications
• CELLESTIAL
• Enzo Therapeutics

Products and services

• AMPIVIEW RNA Probes Proprietary RNA probe technology for in situ hybridization and FISH applications enabling nucleic acid detection in tissue samples; supports spatial biology research and multiomics analysis. Sold to academic researchers, biotech and pharma scientists performing tissue-based studies.
• Antibodies Research antibodies for cellular analysis applications, sold to academic, biotech, pharma, CRO, and diagnostic customers for basic and translational research workflows.
• ELISA Immunoassays Enzyme-linked immunosorbent assay kits for detecting and quantifying small and large analytes accurately and efficiently across protein analysis applications; sold to research and biopharma customers.
• Immunohistochemistry (IHC) Immunohistochemistry products for tissue analysis and visualization used by academic and biopharma researchers.
• CELLESTIAL Cellular Analysis Next-generation fluorescent dyes platform providing high-specificity visualization of cellular responses in cell-based assays; sold to researchers performing cellular analysis.
• Lab Essentials Essential laboratory products and supplies supporting basic research workflows for academic and industry laboratories.
• GMP Services Good Manufacturing Practice services for biopharma including custom manufacturing, packaging, and assay validation testing, backed by ISO 9001 and ISO 13485 certifications.
• Custom Manufacturing & Packaging Services Contract services offering custom manufacturing and packaging for biopharma and diagnostic customers requiring quality-certified production capabilities.
• Bulk Solutions Bulk supply of reagents and products for large-scale research and manufacturing operations serving biopharma and diagnostic customers.
• Enzo Therapeutics Therapeutic development platform covering immune regulation, gene technologies, and cell signaling modulation for drug discovery. Includes licensing opportunities for partners.

Quantifiable outcome

• Over 175,000 scientific citations validating product quality and research impact
• +1 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Bio-Rad is the most directly comparable peer, competing head-to-head with Enzo in ELISA immunoassays, antibodies, and life science research reagents. Both companies are explicitly named together as key players in the ELISA market with overlapping customer bases in academic and biopharma research.
• Bio-Techne (R&D Systems): Bio-Techne, through its R&D Systems brand, competes with Enzo in research antibodies, ELISA kits, and protein analysis reagents, and is also named as a key player in the ubiquitin enzymes market. The company shares Enzo's reagent-plus-services model and academic/biopharma customer base.
• Abcam: Abcam is a leading research antibody supplier that directly competes with Enzo's antibodies and cellular analysis portfolio. Both serve academic and pharma researchers globally with catalog antibodies, conjugation services, and validated reagents for protein and cellular analysis.
• Cell Signaling Technology: Cell Signaling Technology is a key competitor in research antibodies and ELISA kits, particularly for signaling pathway and immunology applications. Enzo lists Enzo Therapeutics work in cell signaling modulation as a platform, putting it in direct product category competition with CST.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology is a direct competitor in research antibodies, particularly monoclonal and polyclonal antibodies used in western blot, IHC, and ELISA workflows. Enzo's IHC and cellular analysis offerings overlap with Santa Cruz's core catalog.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher is explicitly named alongside Enzo as a key player in the flow cytometry market and offers an enormous overlapping portfolio of antibodies, assays, and reagents through its Life Sciences Solutions segment. It is a much larger incumbent but competes across Enzo's entire technology platform set.
• Becton Dickinson (BD Biosciences): BD Biosciences is named alongside Enzo as a key player in the flow cytometry market, including instruments, antibodies, and reagents. While BD is broader and instrument-anchored, it directly overlaps Enzo's flow cytometry reagent offerings.
• MilliporeSigma (Sigma-Aldrich): MilliporeSigma is a broad life sciences tools incumbent offering antibodies, ELISA kits, and lab essentials that compete directly across Enzo's Lab Essentials and protein analysis product lines. It is a meaningful competitor for academic and industrial catalog reagent purchases.
• PerkinElmer (Revvity): Revvity (formerly PerkinElmer) provides life sciences reagents, immunoassays, and analytical tools that overlap Enzo's ELISA and protein analysis offerings. The company also competes in cellular imaging and genomics research reagents.
• Agilent Technologies: Agilent is named alongside Enzo in the flow cytometry market and offers a broader portfolio of analytical instruments, reagents, and pathology solutions. Agilent's cell analysis business acquired from Resolution Bioscience provides direct competition in flow cytometry reagents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/enzolifesci
• Facebookfacebook.com/Enzo.Life.Sciences
• LinkedInlinkedin.com/company/enzo-life-sciences-inc-
• Instagraminstagram.com/enzolifesciences

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enzo Life Sciences